Background: During brain development, a multitude of neuronal networks form as neurons find their correct position within the brain and send out axons to synapse onto specific targets. Altered neuronal connectivity within these complex networks has been reported in Autism Spectrum Disorder (ASD), leading to alterations in brain function and multisensory integration. Semaphorins (also referred to as Semas), a large protein family of about 30 members, have been shown to play an important role in neuronal circuit formation and have been implicated in the etiology of ASD. The purpose of the current study is to investigate how Sema6A mutation affects neuronal connectivity in ASD. Since Sema6A is involved in cell migration, we hypothesized that during brain development the migration of GABAergic interneurons is affected by the loss of Sema6A gene, leading to alterations in Excitatory/Inhibitory (E/I) balance.
conditions (29 cycles): 95°C for 30 seconds, 64°C for 30 seconds, and 72°C for 2 minutes. PCR were run on either a T100 (Bio-rad) or a SimpliAmp (Life Technologies) thermal cycler and were imaged using ChemiDoc Touch Imaging System (Bio-rad).
Immunohistochemistry
Brains were dissected, cryo-protected with 30% sucrose in 1X PBS (phosphate buffer saline), embedded in Optimal Cutting Temperature (OCT -VWR) and sliced at 40µM (Leica, cryostat). Sections were washed in 1X PBS and then blocked for 30 minutes at room temperature in blocking solution (BS) [BS contains 1X Tris Buffer solution (TBS)-0.3% Triton, 1% Donkey Serum, and 1% Bovine serum albumin (BSA)] followed by incubation with primary antibodies at room temperature overnight (see antibody table for details on the primary antibodies that were used in this study). The next day, sections were rinsed in 1X TBS-0.3% Triton and incubated with the corresponding secondary antibodies for two hours at room temperature (see antibody table for details on the secondary antibodies used). For DAB (diaminobenzidine) staining, VECTASTAIN Elite ABC kit was used (Vector Laboratories, PK-6100) at room temperature for 1 hour, sections were rinsed and then incubated at room temperature in DAB (Sigma, cat# D4418). 
Antibodies

Histological analysis:
All images were obtained using an Axio Zoom V16 microscope (Zeiss) and NIH image J software was used for cortical thickness, cortical area and cell number analysis. Histological and cell count analyses were performed blind of genotype (wildtype, heterozygous, or knockout) and sex. Cortical thickness was measured in the primary somatosensory cortex (S1) from bregma levels -1.06 mm to -2.06 mm.
Measurements of cortical area were achieved using a boundary map of the neocortical areas, including motor, somatosensory and auditory cortical areas at bregma levels -1.06 mm to -2.06 mm. Cell number analysis for both GABAergic interneurons, GAD65-GFP and GAD67-GFP, consisted of counting fluorescent GFP positive cells in the primary somatosensory cortex (S1), hippocampus and reticular thalamic nucleus at bregma levels -1.06 mm to -2.06 mm. Analysis of either Parvalbumin, or Calretinin or Calbindin cell number consisted of counting DAB positive cells in the primary somatosensory cortex (S1), hippocampus and reticular thalamic nucleus at bregma levels -1.06 mm to -2.06 mm. A minimum of 7 animals and a maximum of 12 animals were used for all the analysis. There were no significant differences between the cell counts from males and females of the same genotype therefore the data presented in this study combines cell counts obtained from either males or females of the same genotype. Histological data were analyzed using unpaired two-tailed t tests using GraphPad Prism 8.0.0 (GraphPad Software; San Diego, CA), with genotype (Control vs KO) as the main factor. Data are presented as mean ± SEM and statistical significance was set at p ≤ 0.05 -see figure legends for number of animal per analysis and p values.
RESULTS
Both cortical thickness and cortical area were unchanged in Sema6A mutant mice
To investigate whether Sema6A mutants can be used as an informative model to investigate the E/I imbalance seen in ASD, the overall brain anatomy of the Sema6A mutant mice was first analyzed. As previously reported by Runker et al. 2011 [24] , our results showed that Sema6A mutant mice at P30 displayed cortical lamination defects in the auditory cortex (data not shown), however both primary somatosensory cortical ( Fig. 1A and A' compared to Fig. 1B and B') and hippocampal areas ( Fig. 1A and A" compared to Fig. 1B and B"), where our data processing of the GABAergic population focused, appeared to be unaffected by the loss of Sema6A gene. Analysis of the cortical thickness as well as the cortical area revealed no difference between Sema6A mutant and control mice at P30 ( Fig.1C and D, mutant mice n=7, control mice n=7). In order to investigate the contribution of Sema6A toward GABAergic interneuron migration, Sema6A mice were crossed with either GAD65-GFP transgenic mice or GAD67-GFP knock-in mice.
Reduction in GAD65-GFP positive cells in Sema6A KO mice
GABA synthesis from glutamate is dependent upon glutamate decarboxylase (GAD) enzyme. There are two distinct isoforms of GAD, GAD65 (65 kDa form) and GAD67 (67 kDa form), both able to synthesize GABA [34] . GAD65-GFP transgenic mouse line in which all GAD65 inhibitory neurons express GFP [35] has proven to be a very useful tool to visualize GABAergic interneurons considering the relatively low sensitivity of GABA immunoreactivity. Therefore, GAD65-GFP mice were crossed with Sema6A mice to allow for a reliable and robust staining of the GAD65 interneuron population within the Sema6A mouse line and for a better understanding of the type of cells affected by the mutation. In order to match closely the neuronal network alterations seen in adult humans with ASD, GABAergic interneuron expression was analyzed at postnatal stage 30 (P30) as it is considered an adult stage with a completely formed neuronal network. Our results showed that adult Sema6A/GAD65-GFP mutant mice have a reduced number of GAD65-GFP+ cells. This reduction was present in the primary somatosensory cortex (S1) and well as in hippocampal and reticular thalamic nucleus (RTN) areas of Sema6A mutant mice ( Fig. 2 A-A'") compared to Sema6A WT mice ( Fig. 2 B-B '"). Cell counts revealed that GAD65-GFP+ cell number was reduced by 50% in the cortical area ( Fig. 2C , mutant n=8, control n=8), 46% in the hippocampal area ( Fig. 2D, mutant n=8, control n=8), and 62% in the RTN area ( Fig. 2E , mutant n=8, control n=7) compared to the control means for each area. While Sema6A mutant mice displayed such a dramatic loss of GABAergic interneurons, there were no anatomical differences visible ( Fig. 1 ) as measures of both cortical thickness and cortical area revealed no differences between Sema6A mutant and control ( Fig. 1C and 1D) mice.
Reduction in GAD67-GFP positive cells in Sema6A KO mice
Given the distinct biochemical properties and intracellular distributions of GAD67 and GAD65 as well as the expression in distinct neuronal cell types [36] [37] [38] , analysis of both GAD65+ and GAD67+ interneuron populations was required to fully evaluate the contribution of Sema6A toward GABAergic interneuron migration. Therefore GAD67-GFP knock-in mouse line [33] in which all GAD67+ inhibitory neurons express GFP were crossed with Sema6A mice. As previously reported in other studies [38] , our results first showed that GAD67 appears to be the predominant GAD form in the neocortex ( Sema6A mutant mice were compared to Sema6A control mice.
Both Calretinin and Calbindin expressions are not affected in Sema6A KO mice
It is well recognized that PV, CaR, and CaB are useful markers for categorizing interneuron populations as they are expressed by more than 80% of the GABAergic neurons [39] [40] [41] [42] [43] [44] . As this study aimed to investigate the contribution of Sema6A toward GABAergic interneuron populations, along with PV, CaR and CaB expressing interneurons were analyzed in Sema6A mutant mice ( Fig. 6 and Fig. 7 , respectively).
Results showed that the expression of CaR was unaffected by the loss of the Sema6A gene ( Fig. 6 ). When both primary somatosensory cortical and hippocampal areas were analyzed at P30, there were no significant differences in CaR expression in the brain areas when Sema6A mutant mice ( Fig. 6 A, A', A'")
were compared to Sema6A control mice ( Fig. 6B, B' , B'''). Expression of CaR in the RTN brain area was not analyzed since RTN is comprised of 98% of PV interneurons [45] . Cell count analysis was performed in both the cortical (S1) and hippocampal areas and revealed no significant differences (data not shown).
Similarly to the PV expression, CaB expression was analyzed in the same brain areas, except for the RTN area. When cell count analysis was performed there were no differences in both the primary somatosensory cortical ( Fig. 7 A, A' Sema6A mutant mice compared to Fig. 7B , B' control mice) and hippocampal ( Fig. 7 A, A" Sema6A mutant mice compared to Fig. 7B , B" control mice) interneuron cell populations expressing CaB. Taken together these results suggest that of the GABAergic calcium-binding interneurons the loss of Sema6A affects only the PV interneuron population.
DISCUSSION
In the present study we took advantage of genetically modified mouse lines to examine the GABAergic interneuron population when Sema6A gene is knocked out. Knock-in mouse lines expressing either GAD65-GFP or GAD67-GFP were crossed with Sema6A mouse line to examine GABAergic interneuron populations. The advantage of using these two GFP reporter lines is a strong, robust and reliable staining of either GAD65 or GAD67 which facilitates our analysis of the GABAergic interneuron populations in the Sema6A mutant mouse line compared to GABA or GAD65 or GAD67 immunostainings. Our major findings using these genetic manipulations are as follow: 1. Loss of Sema6A gene leads to a dramatic overall GABAergic cell reduction in the primary somatosensory cortical, hippocampal, and RTN brain areas. To our knowledge this is the first study reporting a GABAergic interneuron loss in the RTN, an area known to play a role in the brain's attentional network. 2. Analysis of the subpopulations of inhibitory neurons revealed that the fast spiking interneurons, PV, are the only GABAergic interneurons affected by the Sema6A mutation as CaR and CaB cell populations remain unchanged. 3. Loss of the PV interneuron cell population can be observed in the RTN as early as the first postnatal week, when PV expression is initiated.
Sema6A loss leads to GABAergic cell loss
In this study, we aimed to understand E/I imbalance at a cellular level, and hypothesized that either the production, migration, cell-type specification, or maturation of GABAergic interneurons may be affected in ASD. To this end, Sema6A gene contribution was analyzed to understand whether the loss of this axon guidance molecule can affect GABAergic interneuron populations. Our results showed a reduction in GABAergic cell number in the primary somatosensory cortical, hippocampal, and RTN areas, thereby revealing the importance of Sema6A in the formation of GABAergic neuronal networks in these brain areas. Other studies have previously documented the role of some semaphorin family members in interneuron cell migration during brain development. Sema3A knockout mice display a reduced number of interneurons in the developing cortex due to altered migration [46] [47] [48] [49] . These studies focused only on embryonic stages and did not indicate adult GABAergic interneuron fate, nor which interneuron cell type was affected as a result of the migration defect. Sema3A is not the only member of the semaphorin family to control cortical interneuron migration [46] [47] [48] [49] and cerebellar interneuron branching [50] as studies have described the role of Sema6A in cerebellar granule cell migration [30, 51] . Sema3C, another member of the family, also plays a role in GABAergic fate, as it is implicated in the transient presence of GABAergic interneurons during the formation of the corpus callosum (CC) [52] . It is interesting to note that the loss of these transient GABAergic interneurons in the CC resulted in major pathfinding defects in the CC [52] .
Such defects in CC formation were also reported in Sema3A knockout mice [33, 53] and provide more evidence for a role of semaphorin members in ASD as 1/3 of individuals with autism have an abnormal CC [54] . While most studies have focused on the importance of semaphorins in the control of neuronal migration and axon guidance during brain development, recent studies have reported the role of semaphorins in the maturation of cortical circuits [55, 56] . Indeed failure in GABAergic circuitry formation was described in the Sema7A knockout mice, however the GABAergic cell loss was only reported in layer 4 of the barrel cortex [55] compared to our results showing that all the cortical layers are affected in the Sema6A mutation. More recently, Greg Barnes' group published an informative study on interneuronspecific knockout mouse of Sema3F [56] . Their data showed a 20% reduction of GABAergic cells in the somatosensory cortex while we report a 50% reduction of GAD65-GFP positive cells and 26% reduction of GAD67-GFP positive cells in the same cortical area. The differences in cell number reduction between the 2 studies might be explained by the fact that Sema6A and Sema3F play different roles in either the GABAergic cell production, migration or maturation. Sema7A knockout mice also displayed a GABAergic cell loss in the hippocampus, however it was specifically located in the CA1 area [56] whereas our data showed that in Sema6A mutant mice all the hippocampal sub-regions had a reduction in GABAergic cell number. Taken together, our data suggest the importance of Sema6A gene in either the production, proliferation and/or migration of GABAergic interneurons since the disruption of this gene leads to a GABAergic cell loss in several brain areas.
Loss of Sema6A gene leads to a loss of PV cells
Of the GABAergic interneurons, PV neurons are the most abundant [57, 58] and are involved in the generation of cortical gamma-oscillations that synchronize cortical activity driving cognitive processing [59, 60] . Abnormalities of PV neurons have attracted attention as one of the potential causes underlying neuropsychiatric disorders [11] . Studies on postmortem brains of individuals with schizophrenia, autism, and bipolar disorder have revealed that the number of PV neurons is lower in the frontal cortex, entorhinal cortex, and hippocampus [44, [61] [62] [63] [64] [65] [66] . Several studies using genetic mouse models to investigate the etiology of ASD also reported PV defects in these animal models [21, [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] . As we seek to understand the mechanisms behind human GABAergic defects in ASD, Sema6A knockout mice were crossed with either a knock-in mouse model expressing GAD65-GFP or GAD67-GFP. Since our results showed a loss of GABAergic interneurons in Sema6A knockout mice, we analyzed the expression of different populations of the GABAergic interneurons and found that the PV cell population displayed a reduction in cell number,
whereas CaR and CaB cell populations were unaffected by the mutation. Similar to our observations, in the FMR1 knockout mice. GABAergic cell loss was only targeted to the PV cell population, as no changes in either CaR or CaB were seen [72] . FMR1 knockout mice displayed a 20% reduction in PV cell populations in the somatosensory cortex [72] , while our results showed a more pronounced PV cell density loss with a 46% reduction in the primary somatosensory cortical area. Hippocampal PV cell reduction was also reported in the Neuropilin-2 mutant mouse, with a 42% PV cell reduction [21] compared to the 45% PV cell reduction seen in the Sema6A mutant mice. Since Neuropilin 2 has been shown to interact with
Sema6A [79, 80] , these very similar PV cell losses seen in both Sema6A and Neuropilin 2 knockout mice could suggest that Sema6A interacts with Neuropilin 2 to facilitate the migration of the GABAergic interneurons, and disruption of either leads to alterations of the GABAergic interneurons and more specifically the PV population. CNTNAP2 knockout mice, another well-known ASD model, also displayed a 20% PV cell loss in both the cortical and hippocampal areas [71] . This PV cell reduction was lower than the one we observed in the Sema6A mutant mice, which displayed a 46% and a 45% reduction in the cortical and hippocampal areas, respectively, suggesting that there are different mechanisms controlling the GABAergic interneurons in these two ASD animal models. In the Neuroligin-3 mutant mice, the cortical PV cell loss [68] was very similar to the one we observed in the Sema6A knockout mice (~50%), however no PV cell loss was reported in the hippocampal area, indicating that Neuroligin-3 might only play a role in the fate of cortical GABAergic interneurons, whereas Sema6A might be involved in both hippocampal and cortical GABAergic cell fate. Taken together, it appears that similar to other mouse models that previously reported a PV cell reduction, Sema6A mutant mice also display a PV cell loss, suggesting that in ASD mouse models PV defects could be a common feature. Recent studies on Shank1 and also Shank3 mutant mice suggested the PV reduction observed in both knockout mouse models was due to a PV downregulation rather than a neuronal loss [67, 69, 81, 82] . Based on our results showing an overall GABAergic cell loss, using GAD transgenic mouse lines to reliably visualize GABAergic interneurons, and the fact that neither CaR nor CaB interneurons are affected, we believe that the PV loss that we see in the Sema6A mutant mice is due to a PV cell loss rather than a downregulation of PV.
RTN brain area displayed the greatest GABAergic cell loss in Sema6A mutant mice
The RTN, discovered by Kölliker [83] and located between the internal capsule and the external medullary lamina, originates from the ventral thamalus [84] and receives inputs from the cerebral cortex and dorsal thalamic nuclei [85, 86] . It is sub-divided into several sectors [87] [88] [89] (1 limbic, 1 motor and 5 sensory sectors, including visual, auditory, somatosensory, gustatory and visceral) and GABAergic neurons appear to be the major RTN cell type [90, 91] , with 98% of these GABAergic neurons expressing PV [45] . RTN has been described as a gate keeper [92] and has been shown to play a role in attention [93] [94] [95] [96] [97] , multisensory gating [98] , emotions [97] , sleep [99, 100] , and pain regulation [101] . More recent work by Halassa's group [102] described the RTN as a switchboard regulating the information received by the brain, and more importantly filtering out unnecessary information, thereby reinforcing the importance of the RTN in attention processes and the consequences that might arise if such neural circuits become defective. While
Halassa's group also investigated the role of Ptchd1, a gene mutated in ASD (~1% of all individuals with ASD), and reported RTN impairments using conditional Ptchd1 knockout mouse with attention deficit and hyperactivity, they did not report any loss of any GABAergic interneurons in this brain area [103] . The only PV cell loss that has been reported in the RTN area was found in subjects with either schizophrenia or bipolar disorder [104] . Although GABAergic cell loss and more specifically PV cell loss was reported in several studies using ASD mouse models, the interneuron loss was either seen in the cortical area and/or the hippocampus. Therefore to our knowledge this is the first study reporting a GABAergic interneuron cell loss in the RTN when an axon guidance gene reported as an ASD candidate gene is mutated. The reduction of PV cell number (37%) observed in the RTN of Sema6A mutant mice suggests that Sema6A might play a role in the RTN formation by controlling the migration of the GABAergic interneurons into that area. Sema6A may have a deep impact in the RTN function since such a cell loss might contribute to cognitive, emotional, attentional, sensory, and sleep defects, all of which have been observed in individuals with ASD.
LIMITATIONS
Sema6A mutant mice have been a valuable tool to assess the potential mechanisms altered in ASD, however it is important to acknowledge the limitation of animal models and the degree to which they can match the complexity of the human brain.
CONCLUSIONS
Sema6A gene and its implication in E/I balance
The goal of our study was to focus on the potential role of Sema6A in ASD and assess whether the loss of an axon guidance molecule could affect the proper formation of neuronal circuits by disrupting the GABAergic interneuron population. We did not intend to characterize the Sema6A mutant mice phenotype, since axon guidance, cell migration, and behavioral defects have been previously reported by other groups [27-30, 51, 105-109] , but rather we intended to focus on whether Sema6A mutants can be used as an informative model to investigate the E/I imbalance. As our results showed GABAergic cell loss, and more specifically PV cell loss, in key brain areas involved in ASD, our study revealed the implication of Sema6A E/I imbalance and its role on neurodevelopmental defects/ASD. Indeed, Sema6A mutant mice also displayed cortical lamination defects in the auditory cortex (data not shown, [24] ) similar to the disorganization of the cortical layers reported in individuals with autism [7] , adding evidence to the role of Sema6A in ASD. How PV cells are being disrupted in ASD still remains unclear, however it would appear that since only PV interneurons are affected by the loss of Sema6A, Sema6A is very likely to play a role in the medial ganglionic eminence (MGE) maturation rather than the lateral (LGE) or caudal ganglionic eminence (CGE) maturation which are producing CaR interneurons. Further studies looking at brain development and the generation of interneurons in Sema6A mutant mice will help to elucidate whether the proliferation, migration, or specification of PV interneurons is affected as a mechanism contributing to human GABAergic disruptions in ASD. Calbindin staining was performed on coronal brain sections at P30. No differences in expression were found between the Sema6A mutant mice (A, A' is a high power view of the cortical area, A" is a high magnification of the hippocampal area) and the Sema6A control mice (B, B' is a high power view of the cortical area, B" is a magnification of the hippocampal area). Cell count analysis in the cortical (S1), 
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